Trivalent gets UK green light for flu in over 65s
UK marketing authorisation has been granted for Sanofi Pasteur’s Trivalent Influenza Vaccine High Dose for people 65 years and older.
Read More
Tag: Trivalent Influenza Vaccine High Dose
- MRM Health collaborates with Oncode Institute and Netherlands Cancer Institute
- Sobi to acquire Arthrosi Therapeutics, strengthening gout treatment pipeline
- Lindus Health and Quotient Sciences announce strategic partnership to accelerate drug development
- Title21 Health Solutions joins the Blood and Cells Advocacy Roster
- NADMED launches $30,000 metabolomics research award
